APA

van Brummelen E. M. J., Levchenko E., Dómine M., Fennell D. A., Kindler H. L., Viteri S., Gadgeel S., López P. G., Kostorov V., Morgensztern D., Orlov S., Zauderer M. G., Vansteenkiste J. F., Baker-Neblett K., Vasquez J., Wang X., Bellovin D. I., Schellens J. H. M., Yan L., Mitrica I., DeYoung M. P. & Trigo J. (20210303). A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. : Investigational new drugs.

Chicago

van Brummelen Emilie M J, Levchenko Evgeny, Dómine Manuel, Fennell Dean A, Kindler Hedy L, Viteri Santiago, Gadgeel Shirish, López Pilar Garrido, Kostorov Vladimir, Morgensztern Daniel, Orlov Sergey, Zauderer Marjorie G, Vansteenkiste Johan F, Baker-Neblett Katherine, Vasquez James, Wang Xiaowei, Bellovin David I, Schellens Jan H M, Yan Li, Mitrica Ionel, DeYoung M Phillip and Trigo José. 20210303. A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. : Investigational new drugs.

Harvard

van Brummelen E. M. J., Levchenko E., Dómine M., Fennell D. A., Kindler H. L., Viteri S., Gadgeel S., López P. G., Kostorov V., Morgensztern D., Orlov S., Zauderer M. G., Vansteenkiste J. F., Baker-Neblett K., Vasquez J., Wang X., Bellovin D. I., Schellens J. H. M., Yan L., Mitrica I., DeYoung M. P. and Trigo J. (20210303). A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. : Investigational new drugs.

MLA

van Brummelen Emilie M J, Levchenko Evgeny, Dómine Manuel, Fennell Dean A, Kindler Hedy L, Viteri Santiago, Gadgeel Shirish, López Pilar Garrido, Kostorov Vladimir, Morgensztern Daniel, Orlov Sergey, Zauderer Marjorie G, Vansteenkiste Johan F, Baker-Neblett Katherine, Vasquez James, Wang Xiaowei, Bellovin David I, Schellens Jan H M, Yan Li, Mitrica Ionel, DeYoung M Phillip and Trigo José. A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. : Investigational new drugs. 20210303.